Financial News
Latest News about ABBV
Recent news which mentions ABBV
Got $1,000? 5 Buffett Stocks to Buy and Hold Forever
February 14, 2022
From Motley Fool
From Benzinga
Is the FDA's Partial Hold Bad News for Gilead Investors?
February 12, 2022
From Motley Fool
Is Growth Investing a Thing of the Past?
February 11, 2022
From Motley Fool
2 Green Flags For Gilead Sciences' Future
February 11, 2022
From Motley Fool
2 Dividend Stocks That Are Better Investments Than AT&T
February 11, 2022
From Motley Fool
3 Top Healthcare Stocks to Buy for February
February 08, 2022
From Motley Fool
These 2 Mega-Cap Stalwart Stocks Just Hit All-Time Highs
February 07, 2022
From Motley Fool
AbbVie Wins Yet Another Approval for This Drug
February 07, 2022
From Motley Fool
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Could This New Indication Create a Blockbuster for Pfizer?
February 05, 2022
From Motley Fool
Is AbbVie Stock a Buy Now?
February 05, 2022
From Motley Fool
From Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
From Benzinga
5 Top Stock Trades for Thursday: AMD, NVDA, FB, QCOM, ABBV
February 02, 2022
From InvestorPlace
AbbVie Expects Solid FY22 As Botox, Skyrizi Power Q4 Earnings
February 02, 2022
Tickers
ABBV
From Benzinga
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
February 02, 2022
From Benzinga
A few more stock pullbacks, and then a big one, are coming, warns this manager. Here’s how investors should prepare.
February 02, 2022
From MarketWatch
Earnings Scheduled For February 2, 2022
February 02, 2022
From Benzinga
Is AbbVie Stock a Buy Now?
February 01, 2022
From Motley Fool
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
February 01, 2022
From Benzinga
3 Warren Buffett Dividend Stocks to Buy in February
February 01, 2022
From Motley Fool
3 Pharmaceutical Stocks With Dividend Yields of 2.9% or Better
February 01, 2022
From Motley Fool
5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market Crash
February 01, 2022
From Motley Fool
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
Better Dividend Stock: AbbVie or Pfizer?
January 30, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
